Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

OSE IMMUNOTHERAPEUTICS

(OSE)
  Rapport
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFondsCommunauté 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteurAnalyses Zonebourse
Actualités dans d'autres langues sur OSE IMMUNOTHERAPEUTICS
18/11OSE Immunotherapeutics and the FoRT Foundation Announce First Patient Randomized in Pha..
17/11OSE Immunotherapeutics Presented New Translational Data on Tedopi and Preclinical Data ..
17/11OSE Immunotherapeutics Enrolls First Patient in Phase 2 Study Of Non-Small Cell Lung Ca..
17/11OSE Immunotherapeutics and the FoRT Foundation Announce First Patient Randomized in Pha..
17/11OSE Immunotherapeutics and the FoRT Foundation Announce First Patient Randomized in Pha..
16/11OSE Immunotherapeutics Presented New Translational Data on Tedopi® and Preclinical Data..
16/11OSE Immunotherapeutics Presented New Translational Data on Tedopi? and Preclinical Data..
15/11OSE Immunotherapeutics Presented the First Positive Preclinical Efficacy Data on CLEC-1..
15/11OSE Immunotherapeutics Presents First Positive Preclinical Efficacy Data on CLEC-1
19/10OSE IMMUNOTHERAPEUTICS : to Present New Preclinical Data at Upcoming Bispecific Antibody a..
13/10OSE IMMUNOTHERAPEUTICS : to Host Today a Virtual 'Immuno-Oncology R&D Day'
13/10OSE IMMUNOTHERAPEUTICS : to Present New Clinical and Preclinical Data at the Society for I..
13/10OSE Immunotherapeutics to Present New Clinical and Preclinical Data at the Society for ..
12/10OSE IMMUNOTHERAPEUTICS : to Host Today a Virtual “Immuno-Oncology R&D Day”
11/10GLOBAL MARKETS LIVE : Facebook, Apple, KKR, Adler, Roche...
11/10OSE IMMUNOTHERAPEUTICS : Receives New Patent Regulation For Vaccine Tedopi; Shares Up 5%
11/10OSE IMMUNOTHERAPEUTICS : Receives New European Patent Notice of Allowance for Tedopi® &nda..
11/10OSE IMMUNOTHERAPEUTICS : Receives New European Patent Notice of Allowance for Tedopi®
11/10OSE Immunotherapeutics Receives New European Patent Notice of Allowance for Tedopi®
30/09OSE IMMUNOTHERAPEUTICS : Boehringer Ingelheim and OSE Immunotherapeutics Announce First Pa..
30/09OSE IMMUNOTHERAPEUTICS : Boehringer Ingelheim and OSE Immunotherapeutics Announce First Pa..
30/09Boehringer Ingelheim and OSE Immunotherapeutics Announce First Patient Dosed in Phase 1..
28/09GLOBAL MARKETS LIVE : Airbus, Merck, Geely, Toyota, Activision Blizzard...
28/09OSE IMMUNOTHERAPEUTICS : to Host an 'Immuno-Oncology R&D Day' On October 12th, 2021
27/09OSE IMMUNOTHERAPEUTICS : to Host an “Immuno-Oncology R&D Day” On October 12th,..
21/09OSE IMMUNOTHERAPEUTICS : Announces H1 2021 Results and Provides a Corporate Update
21/09OSE Immunotherapeutics Announces H1 2021 Results and Provides a Corporate Update
21/09Ose Immunotherapeutics Sa Reports Earnings Results for the Half Year Ended June 30, 202..
20/09GLOBAL MARKETS LIVE : Universal Music Group, China Evergrande, ENI, Prudential, Microsoft...
20/09OSE IMMUNOTHERAPEUTICS : Presented Positive Final Results of Tedopi® Phase 3 Clinical Tria..
20/09OSE IMMUNOTHERAPEUTICS : To Present Positive Results of Tedopi® Phase 3 Clinical Trial in ..
20/09OSE IMMUNOTHERAPEUTICS SA(ENXTPA : OSE) added to S&P Global BMI Index
17/09GLOBAL MARKETS LIVE : Ryanair, Ford, Apple, Alphabet, Gap...
16/09OSE IMMUNOTHERAPEUTICS : Boehringer Ingelheim and OSE Immunotherapeutics Present Phase 1 R..
16/09Boehringer Ingelheim and OSE Immunotherapeutics Present Phase 1 Results with First-in-..
16/09Boehringer Ingelheim and OSE Immunotherapeutics Present Phase 1 Results with First-in-C..
14/09OSE IMMUNOTHERAPEUTICS : Boehringer Ingelheim and OSE Immunotherapeutics To Present Phase ..
13/09GLOBAL MARKETS LIVE : Valneva, Walt Disney, ViacomCBS, General Motors, Amazon...
13/09OSE IMMUNOTHERAPEUTICS : Boehringer Ingelheim and OSE Immunotherapeutics to Present Phase ..
13/09OSE Immunotherapeutics SA to Present Phase 1 Results with First-In-Class Sirpa Inhibito..
07/09GLOBAL MARKETS LIVE : Ryanair, Hyundai, Adecco, Goldman Sachs, JD.com...
07/09OSE IMMUNOTHERAPEUTICS : Receives U.S. Patent Notice of Allowance
07/09OSE IMMUNOTHERAPEUTICS : Wins US Patent For Lung Cancer Drug
07/09OSE IMMUNOTHERAPEUTICS : Receives U.S. Patent Notice of Allowance for Tedopi®
02/09GLOBAL MARKETS LIVE : Ford, Walmart, Apple, Volkswagen, Tesla...
02/09OSE IMMUNOTHERAPEUTICS : to Present at the H.C. Wainwright 23rd Annual Global Investment C..
01/09OSE IMMUNOTHERAPEUTICS : to Present at the H.C. Wainwright 23rd Annual Global Investment C..
27/08GLOBAL MARKETS LIVE : Nvidia, Microsoft, Dell, Apple, Uber...
27/08OSE IMMUNOTHERAPEUTICS : Enrolls First Patient in Phase 2 Study of Ovarian Cancer Treatmen..
26/08OSE IMMUNOTHERAPEUTICS : and ARCAGY-GINECO Announce First Patient Randomized in Phase 2 Cl..
26/08OSE Immunotherapeutics and ARCAGY-GINECO Announce First Patient Randomized in Phase 2 C..
26/08GLOBAL MARKETS LIVE : UMG, Delta Air Lines, Shiseido, Qantas, Lonza...
26/08OSE IMMUNOTHERAPEUTICS : Servier and ose immunotherapeutics announce enrollment of first p..
26/08OSE IMMUNOTHERAPEUTICS : Servier Enroll First Patient In Phase-Two Study Of Sjögren's Synd..
25/08Servier and OSE Immunotherapeutics Announce Enrollment of First Patient in OSE-127/S950..
25/08Servier and OSE Immunotherapeutics SA Announces Enrollment of First Patient in OSE-127/..
25/08GLOBAL MARKETS LIVE : Kering, Delta Air Lines, Pfizer, Moderna, Sony...
24/08OSE Immunotherapeutics Announces Upcoming Investor Conferences and R&D Day
20/07GLOBAL MARKETS LIVE : LVMH, Apple, Microsoft, ABB, SoftwareOne...
19/07OSE Immunotherapeutics Announces Voluntary Pause of Enrollment in the CoVepiT Phase 1 S..
19/07OSE Immunotherapeutics SA Announces Voluntary Pause of Enrollment in the CoVepiT Phase ..
12/07GLOBAL MARKETS LIVE : Volkswagen, Amazon, Credit Suisse, Tesla, Walmart...
12/07OSE IMMUNOTHERAPEUTICS : Receives a EUR10 Million Payment Corresponding to the First Tranc..
09/07OSE Immunotherapeutics Receives a €10 Million Payment Corresponding to the First Tranch..
01/07OSE IMMUNOTHERAPEUTICS : Announces Manufacturing Agreement with Cenexi for Clinical Batche..
30/06GLOBAL MARKETS LIVE : Salesforce, Intel, Wisekey...
30/06OSE IMMUNOTHERAPEUTICS : Taps Cenexi To Manufacture COVID-19 Vaccine Candidate
30/06EN DIRECTO DESDE LOS MERCADOS : Acciona, Slack, Flatexdegiro, Orpea, Hella, Salesforce...
30/06OSE Immunotherapeutics Announces Manufacturing Agreement with Cenexi for Clinical Batch..
24/06OSE Immunotherapeutics Reports on its 2021 Virtual Combined General Shareholder's Meeti..
03/06OSE IMMUNOTHERAPEUTICS : Announces Procedures for Virtual Combined General Meeting –..
28/05OSE IMMUNOTHERAPEUTICS : and the FoRT Foundation Announce Initiation of a Phase 2 Clinical..
27/05BRISTOL MYERS SQUIBB : France's OSE Immunotherapeutics Back Italian Combo Trial in Lung Ca..
27/05Ose Immunotherapeutics and the Fort Foundation Announce Initiation of A Phase 2 Clinica..
27/05OSE Immunotherapeutics and the FoRT Foundation Announce Initiation of a Phase 2 Clinica..
1  2  3  4  5  6Suiv.
Prochain événement sur OSE IMMUNOTHERAPEUTICS